Re: CDC Telebriefing on Investigation of Human Cases of Novel Influenza A
Anne Schuchat: About the serology, right. We are working on serologic assays and we are doing, in the midst of serologic surveys, there's a number of ways that those assays would be evaluated. We're working with Mexico on understanding the, what we call the bottom of the pyramid, people who might have had milder illness are really asymptomatic illness but have been exposed and infected with this virus without actually knowing it. We're doing that in some of the areas here in the U.S. that have been affected.
We've actually got some projects going on in the households where people have had an illness to understand what kind of spread there is in the family, both symptomatic and asymptomatic spread, so there's a number of settings where we're trying to understand really how much infection is around a particular case or an outbreak that we're seeing. This, the ser logic testing is rather complicated. It's not a quick type of test. So those tests are -- those studies are ongoing, but we don't expect to have results in the days ahead. They're something that we're working on quickly, but they won't be results we'll be able to share within the next several days for sure. Our next question, please?